ArticleSAGE open medicine2026
Mst1 participates in the progression of severe acute pancreatitis-induced intestinal barrier dysfunction via inhibiting autophagy and enhancing apoptosis.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Severe acute pancreatitis (SAP) is a common emergency condition associated with high mortality. Intestinal barrier dysfunction plays a critical role in the pathogenesis of SAP. Mammalian sterile 20-like kinase 1 (Mst1) has been shown to coordinately regulate autophagy and apoptosis in cardiac and aging-related diseases. However, the precise role of Mst1 in SAP-induced intestinal barrier dysfunction remains largely unknown. This study aimed to investigate the pathophysiological impact of Mst1 on SAP-induced intestinal barrier dysfunction. Methods: Mst1-knockout and wild-type mice were challenged intraperitoneally with caerulein combined with lipopolysaccharide (LPS) to establish an experimental SAP model. TNF-α-stimulated MODE-K cells were used to analyze the impact on autophagy and apoptosis and to elucidate the underlying mechanisms. Results: Mst1 knockout up-regulated tight junction proteins, alleviated apoptosis and enhanced autophagy in the ileocolic mucosa tissue of SAP mice, which consequently improved cumulative survival and alleviated intestinal barrier dysfunction. Conversely, Mst1 overexpression inhibited autophagy and promoted apoptosis in TNF-α-stimulated MODE-K cells. Conclusion: Mst1 plays an important role in SAP-related intestinal barrier dysfunction by inhibiting autophagy and enhancing apoptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.